imphatec Ltd has raised $2.0M in seed funding. The round comes from SynBioVen.
The company is working on drug delivery technology aimed at changing how long-term and chronic diseases are treated.

Get the full imphatec Ltd company profile
Access contacts, investors, buying signals & more
imphatec Ltd has raised $2.0M in seed funding. The round comes from SynBioVen.
The company is working on drug delivery technology aimed at changing how long-term and chronic diseases are treated.
We are pleased to share that imphatec Ltd has closed an oversubscribed 拢1.5M seed round, led by SynBioVen. Patients with chronic conditions carry the burden of a daily medication regime, where non-compliance has serious consequences.
Worryingly, even when medication is taken compliantly, current drug-delivery methods mean only a fraction of the dose is distributed effectively. The drugs are not failing. The delivery is. We have built a novel drug-delivery implant platform which releases medication long-term with no patient input or compliance required, improves effective distribution within the body, and can be customised

Orbio.ai
Orbio combines and curates trusted data to help customers quickly unleash measurable business value. We provide AI & data strategy advisory, solution design, implementation and support services. Our customers are leaders responsible for Finance, HR, Sales, Supply Chain, Marketing and IT functions. Orbio supports a broad range of industries. We define and measure key performance indicators and success criteria to prove substantial value is being delivered. We deliver quick wins in the first 7 days of a project.
$21.0M Series a
today

Micro Thermal Energy Ltd
Micro Thermal Energy introduces Thermawynd庐 - a new technology that will enable generation of green electricity from low temperature heat sources. Using an innovative application of existing technologies and patent-pending designs, the Thermawynd庐 solution will transform heat from shallow geothermal wells and industrial waste heat to electricity. This can be done at local sites and independent from grid infrastructure which makes it highly beneficial for remote locations and areas with grid overload. It is more reliable and at a lower cost than both wind and solar solutions.
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 | ![]() NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Skyfly Technology | Seed | $10.0M | today |
| 2 | ![]() Chatsi | Seed | $2.5M | today |
| 3 |
$1.5M Pre-seed
today
| $7.2B |
| 2y ago |
| 3 | ![]() GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 | ![]() Illumina United States | Unknown | $7.1B | 2y ago |
| 5 | ![]() RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
![]() Sphaira United States |
| Seed |
| $2.5M |
| today |
| 4 | ![]() Frame United States | Seed | $2.8M | today |
| 5 | ![]() Genie Health Singapore | Seed | $3.0M | today |
Trusted by 200+ sales teams
SynBioVen
VENTURE CAPITAL
Reach imphatec Ltd's investors directly from your dashboard.
Start free trial
Beff
Recently received

the-exploration-company
Recently received

Austin Sensing Co.
Recently received